Related Experiment Video
Updated: Jun 4, 2026

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
Published on: November 28, 2010
Immunological and gene therapy for ovarian cancer a technical overview
1Imperial Cancer Research Fund, Medical Oncology Unit, Western General Hospital, Edinburgh, Scotland.
Abstract:
Conventional medical approaches are limited in part on the prognosis of ovarian cancer. Although the advent of platinum- and taxane-based combination chemotherapy represents a significant advance in the treatment of ovarian carcinoma, the 5-yr survival of patients with intraperitoneal (ip) disseminated disease remains poor at only 30-40% (1-3). The vast majority of patients present with disease that is advanced because of transcoelomic spread yet remains locoregionally contained, rather than truly metastatic to distant sites by blood or lymphatic spread.
Related Concept Videos
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Gene Therapy
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...

